Topical Steroid Regimen for Enhanced Recovery after SMILE

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200064542

Enrollment

Unknown

Registered

2022-10-11

Start date

2022-10-11

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recovery after SMILE

Interventions

Group A:no FML

Group B:0.1% FML once every hour

Group C:0.1% FML once every half-hour

Eligibility

Sex/Gender

All

Age

19 Years to 40 Years

Inclusion criteria

Inclusion criteria: One-hundred-eighty patients (360 eyes) who underwent SMILE were enrolled.

Exclusion criteria

Exclusion criteria: Patients that cannot be followed up.

Design outcomes

Primary

Measure	Time frame
Postoperative uncorrected visual acuity;visual quality;non-contact intraocular pressure;	—

Countries

China

Contacts

Public ContactShen Zhengwei

Wuhan Bright Eye Hospital, Eye and ENT Hospital, Fudan University,

532884338@qq.com+86 13606918326

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026